OSI Pharmaceuticals(美國)

OSI Pharmaceuticals

美國OSIPharmaceuticalswww.osip.comOSIPharmaceuticalsInc.致力于通過發現、開發和銷售高質量、創新和差異化的靶向治療藥物，延長癌癥和糖尿病、肥胖癥患者的生命并改善患者的生活質量，實現“調整藥物和改善生活”的目的。OSIPharmaceuticals是的生物科技企業，主要研究、開發和銷售高質量藥品，延長全球癌癥和糖尿病患者的生命 或改善其生活質量。2010年日藥商Astellas40億美元收購美生物技術公司OSI armaceuticalsiscommittedto“shapingmedicineandchanginglives”bydiscovering,developingandcommercializinghigh-quality,novelanddifferentiatedpersonalizedmedicinesdesignedtoextendlifeandimprovethequalityoflifeforpatientswithcanceranddiabetes/obesity.Wespecializeinthediscoveryanddevelopmentofinnovativemoleculartargetedtherapiesthataddresssignificantunmetmedicalneeds,andstrivetoturnpioneeringscienceintobreakthroughtherapiesforpatientssufferingfromlife-threateningdiseases.OurOncologybusinessisanchoredbyourflagshipproduct,Tarceva®(erlotinib),asmallmolecul